217 related articles for article (PubMed ID: 15471857)
1. Overexpression of enzymatically active human cytosolic and mitochondrial thioredoxin reductase in HEK-293 cells. Effect on cell growth and differentiation.
Nalvarte I; Damdimopoulos AE; Nystöm C; Nordman T; Miranda-Vizuete A; Olsson JM; Eriksson L; Björnstedt M; Arnér ES; Spyrou G
J Biol Chem; 2004 Dec; 279(52):54510-7. PubMed ID: 15471857
[TBL] [Abstract][Full Text] [Related]
2. Mitochondrial thioredoxin system: effects of TrxR2 overexpression on redox balance, cell growth, and apoptosis.
Patenaude A; Ven Murthy MR; Mirault ME
J Biol Chem; 2004 Jun; 279(26):27302-14. PubMed ID: 15082714
[TBL] [Abstract][Full Text] [Related]
3. Rapid induction of cell death by selenium-compromised thioredoxin reductase 1 but not by the fully active enzyme containing selenocysteine.
Anestål K; Arnér ES
J Biol Chem; 2003 May; 278(18):15966-72. PubMed ID: 12574159
[TBL] [Abstract][Full Text] [Related]
4. A diterpenoid derivate compound targets selenocysteine of thioredoxin reductases and induces Bax/Bak-independent apoptosis.
Liu J; Mu C; Yue W; Li J; Ma B; Zhao L; Liu L; Chen Q; Yan C; Liu H; Hao X; Zhu Y
Free Radic Biol Med; 2013 Oct; 63():485-94. PubMed ID: 23732520
[TBL] [Abstract][Full Text] [Related]
5. Differential regulation of expression of cytosolic and mitochondrial thioredoxin reductase in rat liver and kidney.
Crosley LK; Méplan C; Nicol F; Rundlöf AK; Arnér ES; Hesketh JE; Arthur JR
Arch Biochem Biophys; 2007 Mar; 459(2):178-88. PubMed ID: 17291446
[TBL] [Abstract][Full Text] [Related]
6. High-level expression in Escherichia coli of selenocysteine-containing rat thioredoxin reductase utilizing gene fusions with engineered bacterial-type SECIS elements and co-expression with the selA, selB and selC genes.
Arnér ES; Sarioglu H; Lottspeich F; Holmgren A; Böck A
J Mol Biol; 1999 Oct; 292(5):1003-16. PubMed ID: 10512699
[TBL] [Abstract][Full Text] [Related]
7. Thioredoxin reductase.
Mustacich D; Powis G
Biochem J; 2000 Feb; 346 Pt 1(Pt 1):1-8. PubMed ID: 10657232
[TBL] [Abstract][Full Text] [Related]
8. Human mitochondrial thioredoxin reductase reduces cytochrome c and confers resistance to complex III inhibition.
Nalvarte I; Damdimopoulos AE; Spyrou G
Free Radic Biol Med; 2004 May; 36(10):1270-8. PubMed ID: 15110392
[TBL] [Abstract][Full Text] [Related]
9. Substrate and inhibitor specificities differ between human cytosolic and mitochondrial thioredoxin reductases: Implications for development of specific inhibitors.
Rackham O; Shearwood AM; Thyer R; McNamara E; Davies SM; Callus BA; Miranda-Vizuete A; Berners-Price SJ; Cheng Q; Arnér ES; Filipovska A
Free Radic Biol Med; 2011 Mar; 50(6):689-99. PubMed ID: 21172426
[TBL] [Abstract][Full Text] [Related]
10. Thioredoxin reductase is irreversibly modified by curcumin: a novel molecular mechanism for its anticancer activity.
Fang J; Lu J; Holmgren A
J Biol Chem; 2005 Jul; 280(26):25284-90. PubMed ID: 15879598
[TBL] [Abstract][Full Text] [Related]
11. Mitochondrial thioredoxin reductase inhibition, selenium status, and Nrf-2 activation are determinant factors modulating the toxicity of mercury compounds.
Branco V; Godinho-Santos A; Gonçalves J; Lu J; Holmgren A; Carvalho C
Free Radic Biol Med; 2014 Aug; 73():95-105. PubMed ID: 24816296
[TBL] [Abstract][Full Text] [Related]
12. Gambogic acid induces apoptosis in hepatocellular carcinoma SMMC-7721 cells by targeting cytosolic thioredoxin reductase.
Duan D; Zhang B; Yao J; Liu Y; Sun J; Ge C; Peng S; Fang J
Free Radic Biol Med; 2014 Apr; 69():15-25. PubMed ID: 24407164
[TBL] [Abstract][Full Text] [Related]
13. Crystal structure and catalysis of the selenoprotein thioredoxin reductase 1.
Cheng Q; Sandalova T; Lindqvist Y; Arnér ES
J Biol Chem; 2009 Feb; 284(6):3998-4008. PubMed ID: 19054767
[TBL] [Abstract][Full Text] [Related]
14. Regulation of the mammalian selenoprotein thioredoxin reductase 1 in relation to cellular phenotype, growth, and signaling events.
Rundlöf AK; Arnér ES
Antioxid Redox Signal; 2004 Feb; 6(1):41-52. PubMed ID: 14980055
[TBL] [Abstract][Full Text] [Related]
15. Impact of trivalent arsenicals on selenoprotein synthesis.
Ganyc D; Talbot S; Konate F; Jackson S; Schanen B; Cullen W; Self WT
Environ Health Perspect; 2007 Mar; 115(3):346-53. PubMed ID: 17431482
[TBL] [Abstract][Full Text] [Related]
16. Human selenium-dependent thioredoxin reductase from HeLa cells: properties of forms with differing heparin affinities.
Gorlatov SN; Stadtman TC
Arch Biochem Biophys; 1999 Sep; 369(1):133-42. PubMed ID: 10462449
[TBL] [Abstract][Full Text] [Related]
17. The A to Z of modulated cell patterning by mammalian thioredoxin reductases.
Dagnell M; Schmidt EE; Arnér ESJ
Free Radic Biol Med; 2018 Feb; 115():484-496. PubMed ID: 29278740
[TBL] [Abstract][Full Text] [Related]
18. Evidence for a functional relevance of the selenocysteine residue in mammalian thioredoxin reductase.
Marcocci L; Flohé L; Packer L
Biofactors; 1997; 6(3):351-8. PubMed ID: 9288405
[TBL] [Abstract][Full Text] [Related]
19. Why is mammalian thioredoxin reductase 1 so dependent upon the use of selenium?
Lothrop AP; Snider GW; Ruggles EL; Hondal RJ
Biochemistry; 2014 Jan; 53(3):554-65. PubMed ID: 24393022
[TBL] [Abstract][Full Text] [Related]
20. Crystal structures of oxidized and reduced mitochondrial thioredoxin reductase provide molecular details of the reaction mechanism.
Biterova EI; Turanov AA; Gladyshev VN; Barycki JJ
Proc Natl Acad Sci U S A; 2005 Oct; 102(42):15018-23. PubMed ID: 16217027
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
